Gene · 3812
Papers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis. | Heliyon | 2023 | 37664697 | PubTator, text mining | PubMed |
| Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway. | Cancer Cell Int | 2023 | 37649034 | PubTator, text mining | PubMed |
| Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. | Front Immunol | 2023 | 37638058 | PubTator, text mining | PubMed |
| The complex HLA-E-nonapeptide in Behçet disease. | Front Immunol | 2023 | 37638008 | PubTator, text mining | PubMed |
| Role of the Killer Immunoglobulin-like Receptor and Human Leukocyte Antigen I Complex Polymorphisms in Kaposi Sarcoma-Associated Herpesvirus Infection. | Open Forum Infect Dis | 2023 | 37636520 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma. | Med Sci Monit | 2023 | 37632137 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Mechanisms of Psoriasis. | Genes (Basel) | 2023 | 37628670 | PubTator, text mining | PubMed |
| Advances in single-cell RNA sequencing and its applications in cancer research. | J Hematol Oncol | 2023 | 37612741 | PubTator, text mining | PubMed |
| Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19. | Front Med (Lausanne) | 2023 | 37601789 | PubTator, text mining | PubMed |
| A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice. | Front Immunol | 2023 | 37600814 | PubTator, text mining | PubMed |
| Molecular regulatory mechanism of key LncRNAs in subclinical mastitic cows with folic acid supplementation. | BMC Genomics | 2023 | 37592228 | PubTator, text mining | PubMed |
| The application of long-read sequencing in clinical settings. | Hum Genomics | 2023 | 37553611 | PubTator, text mining | PubMed |
| Granzymes, IL-16, and poly(ADP-ribose) polymerase 1 increase during wildfire smoke exposure. | J Allergy Clin Immunol Glob | 2023 | 37539354 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes. | Mol Cancer | 2023 | 37516818 | PubTator, text mining | PubMed |
| Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers. | Pharmaceutics | 2023 | 37514187 | PubTator, text mining | PubMed |
| Neoadjuvant Immunotherapy: A Promising New Standard of Care. | Int J Mol Sci | 2023 | 37511609 | PubTator, text mining | PubMed |
| Analysis of Peripapillary Retinal Nerve Fiber Layer Thickness in Acute Anterior Uveitis among Children with HLA-B27-Positive Juvenile Idiopathic Arthritis. | J Clin Med | 2023 | 37510957 | PubTator, text mining | PubMed |
| Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. | J Clin Med | 2023 | 37510895 | PubTator, text mining | PubMed |
| The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma. | Cancers (Basel) | 2023 | 37509400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3812/papers?page=8